Anonymous ID: 1ecc43 June 21, 2024, 8:03 a.m. No.21060629   🗄️.is 🔗kun

>>21060604

> Peer-reviewed case reports, including but not limited to severe inflammatory/autoimmune events of bone marrow (51–55), liver (56–58), skin (59–64), cardiovascular- (65–77), musculoskeletal- (76, 78, 79), endocrine- (80–84), and nervous system (66, 84–87), etc. that sometimes had been fatal, have been steadily increasing. To supplement the case report data, we performed a limited analysis of the publicly available data from the Vaccine Adverse Event Reporting System (VAERS). According to VAERS, all death reports and selected serious events of interest are investigated (89). Compared to all other non-COVID-19 vaccines combined, the incidence of adverse events is far higher for the mRNA-LNP-based COVID-19 vaccines per million doses administered (Figure 1A). Deaths and SAEs also often occurred soon after injection (Figure 1B), making it more likely to be the consequence of the vaccine and not just a random event. Nevertheless, it is essential to emphasize that one cannot establish causation simply by looking at VAERS reports. The causative relationship between the mRNA-LNP vaccine and SAEs has only been officially recognized by the regulatory agencies for peri- and myocarditis affecting primarily young males (90). While most symptomatic patients might be young males, recent, in vivo physiological tests, such as heart glucose uptake, showed a 40% increase in asymptomatic vaccinated patients irrespective of gender and demographics (91), potentially suggesting a much broader impact. These findings are also supported by a postmortem study, in some of which an autopsy revealed heart inflammation and the presence of vaccine RNA (43). Whether the increase in heart attacks and death in young people (92, 93) might be linked to these vaccines remains to be determined.